Ipamorelin 10mg

Description

Ipamorelin is a synthetic growth-hormone secretagogue studied as a ghrelin-receptor agonist in endocrine response mapping and selected gastrointestinal motility programs.

What it is

Ipamorelin is a selective ghrelin-receptor agonist and growth-hormone secretagogue profile investigated in endocrine signaling and postoperative motility research.

Mechanism snapshot

• Activates ghrelin-receptor pathways linked to growth-hormone release.
• Used to characterize secretagogue selectivity and endocrine-response kinetics.
• Investigated in gut-motility models and postoperative ileus translational settings.

Research programs

• Human pharmacokinetic and pharmacodynamic GH-axis studies.
• Postoperative ileus proof-of-concept clinical investigations.
• Comparative secretagogue signaling profiles across peptide classes.

Limitations

• Clinical datasets are relatively narrow and context-specific.
• Mechanistic signaling outcomes do not guarantee broad clinical efficacy.
• Cross-study comparability can be constrained by protocol heterogeneity.

Selected references

• Ipamorelin, the first selective growth hormone secretagogue - PubMed 1998
• Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers - PubMed 1999
• Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients - PubMed 2014
• Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus (NCT00672074) - ClinicalTrials.gov Status snapshot

Ordering

Add this item to your cart, submit your shipping details at checkout, and wait for your order confirmation. Interac e-Transfer instructions are sent after the order request is received.